Opthea (ASX: OPT) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Opthea Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Opthea (ASX: OPT)
Latest News
Share Gainers
Why Arcadium Lithium, Boart Longyear, Opthea, and Orecorp shares are rising today
Healthcare Shares
Why did the Opthea share price dive 9% on Monday?
Share Fallers
Why Beach, Bendigo and Adelaide Bank, Opthea, and Paradigm shares are sinking
Share Fallers
Why Afterpay, Atomo, Opthea, & Sealink shares are falling today
Small Cap Shares
4 small cap ASX shares to watch
Share Fallers
Why Nanosonics, Oil Search, Opthea, & Piedmont Lithium are tumbling
ASX Share Market News
Why Bigtincan, Oil Search, Opthea, & Xref shares are racing higher
Healthcare Shares
Here's why the Opthea (ASX:OPT) share price is soaring 8%
Share Gainers
Why Bigtincan, Opthea, Seven West Media, & Telix shares are charging higher
Share Gainers
Why the Opthea (ASX:OPT) share price is rocketing 12% higher
Healthcare Shares
The ASX healthcare shares Goldman Sachs rates as a buy
Share Gainers
Why Aristocrat Leisure, Opthea, PointsBet, & Spirit are storming higher:
Frequently Asked Questions
-
No, Opthea does not pay shareholder dividends at this time.
-
Opthea Limited listed on the ASX on 18 April 1991.
OPT ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Opthea
Opthea Limited (ASX: OPT) is a clinical-stage biopharmaceutical company. Following the failure of its Phase 3 wet age-related macular degeneration (AMD) trials, the company discontinued that program and relaunched in June 2026 with a new focus on OPT-302 as a potential treatment for lymphangioleiomyomatosis (LAM), a rare lung disease.
Shareholders have been asked to approve a proposed name change to Ceryvyn Therapeutics to reflect the new direction.
OPT Share Price History Data provided by Morningstar.
| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 08 Jul 2026 | $0.01 | $0.00 | 0.00% | 7,777,329 | $0.01 | $0.02 | $0.01 |
| 07 Jul 2026 | $0.01 | $0.00 | 0.00% | 4,723,387 | $0.02 | $0.02 | $0.01 |
| 06 Jul 2026 | $0.02 | $0.00 | 0.00% | 9,873,809 | $0.02 | $0.02 | $0.01 |
| 03 Jul 2026 | $0.01 | $0.00 | 0.00% | 3,708,050 | $0.02 | $0.02 | $0.01 |
| 02 Jul 2026 | $0.02 | $0.00 | 0.00% | 19,796,064 | $0.02 | $0.02 | $0.01 |
| 01 Jul 2026 | $0.01 | $0.00 | 0.00% | 27,096,878 | $0.02 | $0.02 | $0.01 |
